Blood Gas and Electrolyte Analyzers Market growing at a CAGR of 5.7%, and estimated to reach $2,104 million by 2023

Blood Gas And Electrolyte Analyzers

Blood Gas And Electrolyte Analyzers

The market is growing at a faster rate in the developing countries, owing to the increase in the number of patients suffering from chronic diseases

PORTLAND, OREGON, UNITED STATES, September 17, 2021 /EINPresswire.com/ — North America is expected to dominate the global blood gas and electrolyte analyzer market during the forecast period. However, the market is growing at a faster rate in the developing countries, owing to the increase in the number of patients suffering from chronic diseases and improvement in the healthcare facilities.

the global blood gas and electrolyte analyzers market was valued at $1,427 million in 2016, and is projected to garner $2,104 million by 2023, registering a CAGR of 5.7% from 2017 to 2023.

In detail along with the table of contents, please click on the link below:

https://www.alliedmarketresearch.com/request-sample/4608

The increase in the number of patients has led to further analysis of the blood samples and therefore to an increase in the activity of the electrolyte and blood gas analyzers. Advances in blood and gas technology, increased research and healthcare activities contribute to market growth. Government funding also stimulates the global market for blood gas and electrolyte analysis. The Global Blood Gases and Electrolytes Market Report provides a comprehensive assessment of the market. This report provides a comprehensive analysis of the key sectors, trends, drivers, restraints, competitive prospects, and factors that play a significant role in the market.

The portable blood gas analyzers segment accounted for the highest share of the global market in 2016, owing to its advantages, such as ease and flexibility in terms of usage to diagnose blood gas of the patients irrespective of the location and time.

Key Findings of the Blood Gas and Electrolyte Analyzers Market

In 2016, the portable analyzer segment accounted for the highest share of the global blood gas & electrolyte analyzers market.

The ABL Flex segment contributed the highest revenue to the global market in 2016.

The hospital segment is projected to grow at the highest CAGR of 5.9% during the forecast period.

North America market is projected to grow at a CAGR of 4.4% from 2017 to 2023.

Based on product/brand, it is classified into i-STAT, GEM Premier, ABL Flex, RAPID series, Cobas, and other blood gas analyzers. The ABL Flex segment holds the highest share in the global market, as it offers wide range of products ranging from portable to benchtop blood gas analyzers. Based on end user, it is categorized into hospitals, clinics, ambulatory surgical centers, and others. Hospitals hold the highest market share in the global market, owing to the rise in number of patients treated in ICUs, NICUs, and emergency departments, where the utilization of blood gas analyzers is high to treat patients in critical conditions.

Geographically, North America dominated the global market in 2016, and is estimated to continue its dominance during the forecast period. This is attributed to higher adoption for technologically advanced devices, well-equipped healthcare facilities, and rise in admission of patients in ICUs, NICUs, and emergency departments.

Connect Analyst:

https://www.alliedmarketresearch.com/connect-to-analyst/388

Leading market players

Instrumentation Laboratory (A Werfen Company) (U.S.)
Siemens AG (Germany)
Roche Diagnostics Limited (Switzerland)
Abbott Laboratories, Inc. (U.S.)
Nova Biomedical (U.S.)
OPTI Medical Systems, Inc. (A Subsidiary of Idexx Laboratories, Inc.) (U.S.)
ERBA Diagnostics Mannheim GmbH (Germany)
Medica Corporation (U.S.)
Alere, Inc. (U.S.)

Allied Market Research Coverage on the Healthcare Domain

Micromanipulators Market By Type (Hydraulic, Electric, Manual) and By Application (Embryonic stem cell transfer, Intra-cytoplasmic sperm injection (ICSI), Pronuclear zygote injection, Embryo reconstruction, Microsurgical, Biopsy, Industrial Micromanipulation, microelectronics, Flat screens, packaged parts and probing functions, drug discovery) – Global Opportunity Analysis and Industry Forecast, 2021 – 2028

Liver Disease Treatment Market by Treatment Type (Anti-Rejection Drugs/Immunosupressants, Chemotherapy Drugs, Targeted therapy, Vaccines, Anti-Viral Drugs, IImmunoglobulins, Corticosteroids) – Global Opportunity Analysis and Industry Forecast, 2020 – 2027

We have also published few syndicated market studies in the other trending area that might be of your interest. Below are the titles of the reports for your reference, considering the Impact of Covid-19 on This Market which will help you to assess the aftereffects of a pandemic on short-term and long-term growth trends of this market.

About Us:

Allied Market Research (AMR) is a full-service market research and business -consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of “Market Research Reports” and “Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

David Correa
Allied Analytics LLP
+1 503-894-6022
email us here
Visit us on social media:
Facebook
Twitter
LinkedIn


Source: EIN Presswire